Author:
Lin Xiaodong,Zhao Liangcai,Tang Shengli,Zhou Qi,Lin Qiuting,Li Xiaokun,Zheng Hong,Gao Hongchang
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Bluestone, J. A., Herold, K. & Eisenbarth, G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464, 1293–1300 (2010).
2. Guariguata, L. et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103, 137–149 (2014).
3. Kharitonenkov, A. et al. FGF-21 as a novel metabolic regulator. J Clin Invest 115, 1627–1635 (2005).
4. Wente, W. et al. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 55, 2470–2478 (2006).
5. Wu, A. L. et al. Amelioration of type 2 diabetes by antibody-mediated activation of fibroblast growth factor receptor 1. Sci Transl Med 3, 113–126 (2011).
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献